Gufic Biosciences Balance Sheet Health
Financial Health criteria checks 5/6
Gufic Biosciences has a total shareholder equity of ₹5.7B and total debt of ₹2.8B, which brings its debt-to-equity ratio to 49.4%. Its total assets and total liabilities are ₹11.0B and ₹5.3B respectively. Gufic Biosciences's EBIT is ₹1.3B making its interest coverage ratio 9. It has cash and short-term investments of ₹194.0M.
Key information
49.4%
Debt to equity ratio
₹2.84b
Debt
| Interest coverage ratio | 9x |
| Cash | ₹193.96m |
| Equity | ₹5.74b |
| Total liabilities | ₹5.30b |
| Total assets | ₹11.05b |
Recent financial health updates
Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17
These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13Recent updates
There's Reason For Concern Over Gufic Biosciences Limited's (NSE:GUFICBIO) Massive 26% Price Jump
Nov 07We Think You Should Be Aware Of Some Concerning Factors In Gufic Biosciences' (NSE:GUFICBIO) Earnings
Jun 06Is Gufic Biosciences (NSE:GUFICBIO) Using Too Much Debt?
Jun 17These 4 Measures Indicate That Gufic Biosciences (NSE:GUFICBIO) Is Using Debt Reasonably Well
Sep 02Should You Be Adding Gufic Biosciences (NSE:GUFICBIO) To Your Watchlist Today?
May 07Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 07This Is The Reason Why We Think Gufic Biosciences Limited's (NSE:GUFICBIO) CEO Might Be Underpaid
Sep 15Is Now The Time To Put Gufic Biosciences (NSE:GUFICBIO) On Your Watchlist?
Aug 12Gufic Biosciences' (NSE:GUFICBIO) Performance Is Even Better Than Its Earnings Suggest
Jun 11If You Like EPS Growth Then Check Out Gufic Biosciences (NSE:GUFICBIO) Before It's Too Late
Mar 19What Percentage Of Gufic Biosciences Limited (NSE:GUFICBIO) Shares Do Insiders Own?
Mar 01Gufic Biosciences (NSE:GUFICBIO) Has A Pretty Healthy Balance Sheet
Feb 11Is Gufic Biosciences' (NSE:GUFICBIO) 164% Share Price Increase Well Justified?
Jan 23
Why Gufic Biosciences Limited (NSE:GUFICBIO) Looks Like A Quality Company
Jan 05Here's Why I Think Gufic Biosciences (NSE:GUFICBIO) Is An Interesting Stock
Dec 18Here's What Gufic Biosciences Limited's (NSE:GUFICBIO) Shareholder Ownership Structure Looks Like
Dec 01Gufic Biosciences (NSE:GUFICBIO) Has A Somewhat Strained Balance Sheet
Nov 13The Gufic Biosciences (NSE:GUFICBIO) Share Price Has Gained 116%, So Why Not Pay It Some Attention?
Oct 19Can Gufic Biosciences Limited's (NSE:GUFICBIO) ROE Continue To Surpass The Industry Average?
Sep 14I Built A List Of Growing Companies And Gufic Biosciences (NSE:GUFICBIO) Made The Cut
Aug 24Investors Appear Satisfied With Gufic Biosciences Limited's (NSE:GUFICBIO) Prospects
Aug 03Earnings Tell The Story For Gufic Biosciences Limited (NSE:GUFICBIO)
Jul 09Financial Position Analysis
Short Term Liabilities: GUFICBIO's short term assets (₹5.8B) exceed its short term liabilities (₹3.5B).
Long Term Liabilities: GUFICBIO's short term assets (₹5.8B) exceed its long term liabilities (₹1.8B).
Debt to Equity History and Analysis
Debt Level: GUFICBIO's net debt to equity ratio (46%) is considered high.
Reducing Debt: GUFICBIO's debt to equity ratio has reduced from 123.8% to 49.4% over the past 5 years.
Debt Coverage: GUFICBIO's debt is well covered by operating cash flow (24.6%).
Interest Coverage: GUFICBIO's interest payments on its debt are well covered by EBIT (9x coverage).